Patients' Access to Treatments Act of 2015
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 25, 2015)
Patients' Access to Treatments Act of 2015
Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.
What just happenedMar 27, 2015
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 25, 2015
- Mar 27, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 25, 2015IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 25, 2015IntroReferralIntro-H
Introduced in House
- Mar 25, 2015IntroReferral1000
Introduced in House